What is INmune Bio Inc?
, a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 25.60M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.